Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,602,680
-
Share change
-
-61,132
-
Total reported value
-
$19,384,102
-
Put/Call ratio
-
0%
-
Price per share
-
$7.45
-
Number of holders
-
21
-
Value change
-
-$244,749
-
Number of buys
-
11
-
Number of sells
-
7
Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) as of Q1 2023
As of 31 Mar 2023,
BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,602,680 shares.
The largest 10 holders included
Lynwood Capital Management Inc., WASATCH ADVISORS LP, Redmond Asset Management, LLC, K.J. Harrison & Partners Inc, MORGAN STANLEY, Summit Trail Advisors, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BANK OF MONTREAL /CAN/, Concord Wealth Partners, and HighTower Advisors, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.